FDA grants molecular test for intestinal bacteria 510(k) clearance — 3 insights

The FDA awarded Becton, Dickinson and Company’s BD Max’s extended enteric bacterial panel 510(k) clearance.

Advertisement

Here’s what you should know:

1. BD Max is a molecular test which can detect intestinal bacteria that causes infectious diarrhea.

2. The test detects the majority of pathogens which cause acute gastroenteritis.

3. The extended enteric bacterial panel joins the enteric bacterial panel and the enteric parasite panel in the BD Max suite of offerings.

More articles on gastroenterology:
Gut microbiome-based IBS associated with brain structure alterations — 5 study insights
GI leader to know: Dr. John Haydek of Gastrointestinal Associates
Takeda plans to relocate 100 researchers to US — 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.